Roth Capital Starts Flex Pharma (FLKS) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
Go back to Roth Capital Starts Flex Pharma (FLKS) at Buy
February 23, 2015 7:34 AM EST
JMP Securities initiated coverage on Flex Pharma (NASDAQ: FLKS) with a Market Outperform rating and a price target of $30.00.
For an analyst ratings summary and ratings history on Flex Pharma click here. For more ratings news on Flex Pharma click here.
Shares of Flex Pharma closed at $14.71 yesterday.
...
More
February 23, 2015 7:34 AM EST
Cantor Fitzgerald initiated coverage on Flex Pharma (NASDAQ: FLKS) with a Buy rating and a price target of $22.00.
For an analyst ratings summary and ratings history on Flex Pharma click here. For more ratings news on Flex Pharma click here.
Shares of Flex Pharma closed at $14.71 yesterday.
...
More
February 23, 2015 7:15 AM EST
Jefferies initiates coverage on Flex Pharma (NASDAQ: FLKS) with a Buy rating and a price target of $25.00.
Analyst Ryan Martins comments, "FLKS' proprietary formulation of transient receptor potential (TRP) ion channel activators is well positioned to address muscle cramps and other neuromuscular... More
February 23, 2015 6:50 AM EST
Piper Jaffray initiates coverage on recent IPO Flex Pharma (NASDAQ: FLKS) with a Overweight rating and a price target of $25.00.
Analyst Joshua Schimmer commented, "We are initiating coverage of Flex Pharma with an OW rating and $25 PT, representing ~70% upside from... More
